CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 108 filers reported holding CYTOKINETICS INC in Q1 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $18,000 | -41.9% | 1,666 | -37.5% | 0.00% | – |
| Q3 2019 | $31,000 | +3.3% | 2,666 | 0.0% | 0.00% | – |
| Q2 2019 | $30,000 | -62.0% | 2,666 | -72.4% | 0.00% | -100.0% |
| Q1 2019 | $79,000 | +27.4% | 9,666 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $62,000 | -34.7% | 9,666 | -0.5% | 0.00% | 0.0% |
| Q3 2018 | $95,000 | +239.3% | 9,717 | +144.1% | 0.00% | – |
| Q2 2018 | $28,000 | 0.0% | 3,981 | 0.0% | 0.00% | – |
| Q1 2018 | $28,000 | -12.5% | 3,981 | +1.0% | 0.00% | – |
| Q4 2017 | $32,000 | -43.9% | 3,941 | +0.6% | 0.00% | -100.0% |
| Q3 2017 | $57,000 | +54.1% | 3,918 | +26.4% | 0.00% | – |
| Q2 2017 | $37,000 | -7.5% | 3,100 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $40,000 | +66.7% | 3,100 | +55.0% | 0.00% | – |
| Q4 2016 | $24,000 | +33.3% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $18,000 | -5.3% | 2,000 | -2.2% | 0.00% | – |
| Q2 2016 | $19,000 | -47.2% | 2,045 | -60.2% | 0.00% | -100.0% |
| Q1 2016 | $36,000 | +89.5% | 5,135 | +176.1% | 0.00% | – |
| Q4 2015 | $19,000 | +1800.0% | 1,860 | +1020.5% | 0.00% | – |
| Q4 2013 | $1,000 | 0.0% | 166 | 0.0% | 0.00% | – |
| Q3 2013 | $1,000 | – | 166 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |